Panel discussion on mantle cell lymphoma
Constantine Tam et al.
ASH 2014: Recent advances in the management of mantle cell lymphoma (MCL)
ASH 2014: Phase III Lyma trial of rituximab maintenance after ASCT in mantle cell lymphoma
ASH highlights in CLL and lymphoma by Dr Andrew Zelenetz
Mechanism of action of venetoclax (ABT-199) and its side effects